2,227 research outputs found
A randomized control trial for low back pain treated by acupressure and physical therapy
No full text
A Markov Chain Model to Assess a Multi-centered Screening Project for Breast Cancer in Taiwan
No full textCorrelation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors
No full textThe influence of bolus volume, temperature, and viscosity to swallowing function evaluated by a self-designed phagometer: A preliminary study.
No full textRIC-HSCT for MF/SS
Full text linkAdvanced-stage mycosis fungoides and Sezary syndrome (MF/SS) have a poor prognosis. Allogeneic hematopoietic stem cell transplantation (HSCT), particularly using a reduced-intensity conditioning (RIC) regimen, is a promising treatment for advanced-stage MF/SS. We performed RIC-HSCT in nine patients with advanced MF/SS. With a median follow-up period of 954days after HSCT, the estimated 3-year overall survival was 85.7% (95% confidence interval, 33.4-97.9%) with no non-relapse mortality. Five patients relapsed after RIC-HSCT; however, in four patients whose relapse was detected only from the skin, persistent complete response was achieved in one patient, and the disease was manageable in other three patients by the tapering of immunosuppressants and donor lymphocyte infusion, suggesting that graft-versus-lymphoma effect and "down-staging" effect from advanced stage to early stage by HSCT improve the prognosis of advanced-stage MF/SS. These results suggest that RIC-HSCT is an effective treatment for advanced MF/SS
Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.
No full text
- …
